Tag: Dr Yuelei Shen

Biocytogen signs antibody license agreement with Pheon Therapeutics

businessnewstoday- July 5, 2023

Biocytogen Pharmaceuticals, a global biotech firm specialising in novel antibody therapeutics, has agreed to a licensing deal with Pheon Therapeutics, an antibody-drug conjugate (ADC) developer. ... Read More